Clinical trial
Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Hong Kong and Taiwan
NCT04703855 is registered in ClinicalTrials.gov with Abbott Medical Devices as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Post Market Surveillance of the HeartMate 3 Left Ventricular Assist System in Hong Kong and Taiwan
- Lead sponsor
- Abbott Medical Devices
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- July 14, 2021
- Completion date
- June 30, 2022
- Enrollment
- 3 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
advanced heart failure